Phone: (+91) 77-9295-9295 | info@aprazer.in
Mon-Sat (10:00 AM - 6:00 PM)
Facebook Twitter Instagram linkedin
Facebook Twitter Instagram linkedin
  • Phone: (+91) 7792-959-295
  • info@aprazerhealthcare.com
Aprazer Healthcare Private Limited Aprazer Healthcare Private Limited
  • Home
  • About Us
  • The Leadership
  • Products
    • Oncology
      • Orals
      • Injectables
    • Hepatology
      • Hep-B
      • Hep-C
    • Gastroenterology
    • Nephrology
    • ED
    • Critical Care
    • Focus Therapy
    • HIV
    • Rheumatology
  • News & Media
  • Career
  • Contact Us
Aprazer Healthcare Private Limited Aprazer Healthcare Private Limited
Menu
Dacikast
Click to enlarge
HomeHepatologyHep-C Dacikast
Previous product
Sutekast 12.5
Back to products
Next product
Sofokast Plus

Dacikast

Daclatasvir Tablets 60 mg

Send Enquiry

Thank you for your enquiry. We will get back to you shortly!

Categories: Hepatology, Hep-C
  • Description
  • Download Product PDF Attachment
Description

COMPOSITION: Each tablet contains DACLATASAVIR DIHYDOCHOLORIDE 60 mg

INDICATION: DACIKAST is a hepatitis C virus NS5A inhibitor indicated for use with Sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 Infection.

PACKING: 28 Tablets / Bottle

Download Product PDF Attachment

Related products

Close

Entekor – 1 (90 Tablets)

Entecavir Tablets IP 0.5 mg
Read more
Quick view
Close

Entekor – 1 (30 Tablets)

Entecavir Tablets IP 1 mg
Read more
Quick view
Close

Velakast

Sofosbuvir 400 mg + Velpatasavir 100 mg Tablets

Read more
Quick view
Close

Ledikast

Ledipasvir & Sofosbuvir Tablets

Read more
Quick view
Close

Entekor- 0.5 (90 Tablets)

Entecavir 0.5 mg
Read more
Quick view
Close

Entekor- 0.5 (30 Tablets)

Entecavir Tablets IP 0.5 mg
Read more
Quick view
Close

Tafsure

Tenofovir Alafenamide 25 mg

Read more
Quick view
Close

Sofokast

Sofosbuvir Tablets 400 mg

Read more
Quick view

Disclaimer : This medical information is intended only for healthcare professionals in India. The products discussed herein may have different product labeling in other countries. The information within this site is intended to provide balanced, scientific, and evidence based answers to unsolicited medical questions. For full Prescribing Information including indications, contraindications, warnings, precautions, and adverse events, please submit a medical information request. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. The website does not sell/ purchase any medicine.

© 2023, Aprazer. All Rights Reserved.
  • Home
  • About Us
  • The Leadership
  • Products
    • Oncology
      • Orals
      • Injectables
    • Hepatology
      • Hep-B
      • Hep-C
    • Gastroenterology
    • Nephrology
    • ED
    • Critical Care
    • Focus Therapy
    • HIV
    • Rheumatology
  • News & Media
  • Career
  • Contact Us
Scroll To Top